pfizer - Search News

Pfizer Exec Booed During White House Appearance

Newsweek on MSN · 19h

Trump Introducing Pfizer CEO Sparks Loud Booing Inside White House

A study by KFF found that one in four Republican parents now say they've skipped or delayed some childhood vaccines as of January 2025.

Hosted on MSN · 1d

Pfizer Exec Booed During White House Appearance as Trump Calls Pharma Head 'Great Businessman'

President Donald Trump's introduction of a Pfizer executive at the White House Wednesday was met with a roar of boos from the crowd.

Irish Star on MSN · 1d

Trump giggles as White House crowd brutally boos head of Pfizer being introduced

The CEO of Pfizer was brutally booed at a press conference Donald Trump held in the White House in commemoration of Black History Month in an awkward moment that involved several similar introductions

Pfizer shelves haemophilia gene therapy Beqvez

Hosted on MSN · 20h

Pfizer stops commercialization of hemophilia gene therapy Beqvez

Pfizer said on Thursday it will stop global development and commercialization of its hemophilia gene therapy, Beqvez, citing soft demand from patients and their doctors. Beqvez is a one-time therapy that was approved in the U.

FiercePharma · 17h

Pfizer discontinues hemophilia treatment Beqvez, emptying its gene therapy portfolio

Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. | Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia B product Beqvez.

BioSpace · 17h

Pfizer Axes Beqvez Worldwide, Pivoting Away From Gene Therapy for Hemophilia

The move comes weeks after Pfizer terminated its partnership with Sangamo Therapeutics for another hemophilia gene therapy.

Fact Check: Has Pfizer released a list of side effects for COVID vaccine?

An archived Facebook post claimed that Pfizer has released a list of side effects for COVID vaccine. The claim by the user is ...

2h

Stock Traders Buy High Volume of Call Options on Pfizer (NYSE:PFE)

Pfizer Inc. (NYSE:PFE – Get Free Report) was the target of some unusual options trading activity on Friday. Stock traders ...

An awkward moment for Pfizer’s Bourla in Washington

The future of the CDC’s vaccine advisory committee seems uncertain: A scheduled February meeting for the ACIP, which advises ...

16h

Pfizer: Investors Won't Stick Around Forever

Pfizer may appeal to income investors, but growth prospects remain uncertain. Read why PFE stock might struggle to gain ...

3don MSN

3 Things You Need to Know If You Buy Pfizer Today

We can refer to full-year 2019 revenue of about $51 billion and the company's comments about potential revenue of more than ...

Pharmalittle: We’re reading about RFK Jr. targeting CDC and FDA advisers, a Pfizer gene therapy, and more

HHS Secretary Robert F. Kennedy Jr. is preparing to remove committee members who advise the government on vaccine approvals ...

2d

Why Pfizer's Stock Price Isn't Reflecting Its True Value

Pfizer's strong Q4 2024 results showcase growth in cancer drugs and Vyndaqel sales. Learn why PFE stock is a top pick for ...

8d

Are Investors Being Too Paranoid About Pfizer Stock?

All this negativity, however, does open up an opportunity for investors to buy the stock at a discount. Despite being a top ...

11h

Pfizer's pullback from gene therapy puts spotlight on North Carolina operations

One of the largest pharmaceutical companies in North Carolina is discontinuing a treatment produced in the state.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results